vs
Side-by-side financial comparison of WRAP TECHNOLOGIES, INC. (WRAP) and XOMA Royalty Corp (XOMA). Click either name above to swap in a different company.
WRAP TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($1.4M vs $1.1M, roughly 1.3× XOMA Royalty Corp). XOMA Royalty Corp runs the higher net margin — 554.8% vs -280.9%, a 835.7% gap on every dollar of revenue. On growth, XOMA Royalty Corp posted the faster year-over-year revenue change (83.3% vs 62.3%). Over the past eight quarters, XOMA Royalty Corp's revenue compounded faster (4.9% CAGR vs -2.5%).
Wrap Technologies, Inc. develops non-lethal safety solutions for law enforcement, corrections, and private security sectors across North America and global markets. Its core products include remote restraint devices and training services designed to reduce use-of-force injuries and improve public safety outcomes.
XOMA Royalty Corp is a biopharmaceutical royalty investment and management firm that acquires and holds royalty interests in commercial-stage and late-clinical development therapeutic products. It partners with biotech and pharmaceutical companies worldwide, generating revenue from sales of approved medicines across key segments including oncology, immunology and rare diseases.
WRAP vs XOMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $1.1M |
| Net Profit | $-3.9M | $6.1M |
| Gross Margin | 52.3% | — |
| Operating Margin | -281.1% | — |
| Net Margin | -280.9% | 554.8% |
| Revenue YoY | 62.3% | 83.3% |
| Net Profit YoY | 48.1% | 253.8% |
| EPS (diluted) | — | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $1.1M | ||
| Q3 25 | $1.5M | $225.0K | ||
| Q2 25 | $1.0M | $5.0M | ||
| Q1 25 | $765.0K | $4.0M | ||
| Q4 24 | $865.0K | $600.0K | ||
| Q3 24 | $593.0K | $25.0K | ||
| Q2 24 | $1.6M | $5.0M | ||
| Q1 24 | $1.5M | $1.0M |
| Q4 25 | $-3.9M | $6.1M | ||
| Q3 25 | $-2.8M | $14.1M | ||
| Q2 25 | $-3.7M | $9.2M | ||
| Q1 25 | $109.0K | $2.4M | ||
| Q4 24 | $-7.6M | — | ||
| Q3 24 | $2.0M | $-17.2M | ||
| Q2 24 | $-385.0K | $16.0M | ||
| Q1 24 | $117.0K | $-8.6M |
| Q4 25 | 52.3% | — | ||
| Q3 25 | 59.2% | — | ||
| Q2 25 | 48.1% | — | ||
| Q1 25 | 77.8% | — | ||
| Q4 24 | 47.4% | — | ||
| Q3 24 | 39.6% | — | ||
| Q2 24 | 62.6% | — | ||
| Q1 24 | 56.6% | — |
| Q4 25 | -281.1% | — | ||
| Q3 25 | -185.2% | -591.1% | ||
| Q2 25 | -282.2% | 91.6% | ||
| Q1 25 | -512.7% | — | ||
| Q4 24 | -535.5% | — | ||
| Q3 24 | -611.5% | -62560.0% | ||
| Q2 24 | -201.5% | -200.6% | ||
| Q1 24 | -280.4% | -700.4% |
| Q4 25 | -280.9% | 554.8% | ||
| Q3 25 | -186.0% | 6244.9% | ||
| Q2 25 | -368.3% | 182.9% | ||
| Q1 25 | 14.2% | 59.2% | ||
| Q4 24 | -878.3% | — | ||
| Q3 24 | 335.6% | -68972.0% | ||
| Q2 24 | -24.5% | 318.1% | ||
| Q1 24 | 7.9% | -859.5% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-0.06 | $0.70 | ||
| Q2 25 | $-0.07 | $0.44 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.04 | $-1.59 | ||
| Q2 24 | $-0.02 | $0.84 | ||
| Q1 24 | — | $-0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5M | $82.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $83.9M |
| Total Assets | $15.4M | $272.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5M | $82.9M | ||
| Q3 25 | $6.0M | $45.2M | ||
| Q2 25 | $4.2M | $75.1M | ||
| Q1 25 | $6.2M | $90.3M | ||
| Q4 24 | $3.6M | $101.7M | ||
| Q3 24 | $4.9M | $142.1M | ||
| Q2 24 | $4.6M | $143.9M | ||
| Q1 24 | $8.2M | $136.2M |
| Q4 25 | $11.5M | $83.9M | ||
| Q3 25 | $14.1M | $87.9M | ||
| Q2 25 | $11.8M | $72.4M | ||
| Q1 25 | $2.6M | $84.6M | ||
| Q4 24 | $250.0K | $61.9M | ||
| Q3 24 | $6.4M | $84.8M | ||
| Q2 24 | $3.8M | $100.0M | ||
| Q1 24 | $4.5M | $82.3M |
| Q4 25 | $15.4M | $272.7M | ||
| Q3 25 | $18.2M | $263.2M | ||
| Q2 25 | $15.6M | $223.5M | ||
| Q1 25 | $18.0M | $212.8M | ||
| Q4 24 | $15.1M | $221.3M | ||
| Q3 24 | $18.8M | $223.3M | ||
| Q2 24 | $21.8M | $243.3M | ||
| Q1 24 | $24.8M | $219.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-5.5M |
| Free Cash FlowOCF − Capex | $-2.7M | — |
| FCF MarginFCF / Revenue | -190.3% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | — | -0.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-10.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-5.5M | ||
| Q3 25 | $-2.6M | $-296.0K | ||
| Q2 25 | $-1.9M | $6.5M | ||
| Q1 25 | $-3.1M | $2.2M | ||
| Q4 24 | $-1.2M | $-13.7M | ||
| Q3 24 | $330.0K | $-8.6M | ||
| Q2 24 | $-3.5M | $2.7M | ||
| Q1 24 | $-3.7M | $-4.9M |
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.7M | — | ||
| Q2 25 | $-1.9M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $-1.2M | $-13.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-3.7M | $-5.0M |
| Q4 25 | -190.3% | — | ||
| Q3 25 | -181.1% | — | ||
| Q2 25 | -192.3% | — | ||
| Q1 25 | -401.4% | — | ||
| Q4 24 | -139.5% | -2294.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | -224.2% | — | ||
| Q1 24 | -253.3% | -496.4% |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.1% | 3.3% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.9% | 1.7% |
| Q4 25 | — | -0.90× | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | -28.16× | 0.93× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | -31.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
